AAAAAA
Results:
1-9
|
Results: 9
Authors:
Morabito, F
Mangiola, M
Oliva, B
Stelitano, C
Callea, V
Deaglio, S
Iacopino, P
Brugiatelli, M
Malavasi, F
Citation: F. Morabito et al., Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia, LEUK RES, 25(11), 2001, pp. 927-932
Authors:
Gobbi, PG
Ghirardelli, ML
Cavalli, C
Baldini, L
Broglia, C
Clo, V
Berte, R
Ilariucci, F
Carotenuto, M
Piccinini, L
Stelitano, C
Attardo-Parrinello, G
Ascari, E
Citation: Pg. Gobbi et al., The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas, HAEMATOLOG, 85(4), 2000, pp. 372-380
Authors:
Gobbi, PG
Ghirardelli, ML
Avanzini, P
Baldini, L
Quarta, G
Stelitano, C
Broglia, C
Loni, C
Silingardi, V
Ascari, E
Citation: Pg. Gobbi et al., A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian Lymphoma Study Group (GISL), HAEMATOLOG, 85(3), 2000, pp. 263-268
Authors:
Stelitano, C
Baldini, L
Pieresca, C
Callea, V
Angrilli, F
Clo, V
Partesotti, G
Merli, F
Cavanna, L
Morabito, F
Federico, M
Brugiatelli, M
Silingardi, V
Citation: C. Stelitano et al., Validation of the International Prognostic Index in Working Formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry, HAEMATOLOG, 85(2), 2000, pp. 154-159
Authors:
Callea, V
Stelitano, C
Callea, I
Console, G
Brugiatelli, M
Morabito, F
Citation: V. Callea et al., In vitro drug-induced cytotoxicity predicts clinical response to high-dosechlorambucil in B-cell chronic lymphocytic leukemia, HAEMATOLOG, 84(9), 1999, pp. 863-864
Authors:
Longo, G
Fiorani, C
Sacchi, S
Callea, V
Lombardo, M
Federico, M
Stelitano, C
Angrilli, F
Vallisa, D
Gobbi, PG
Ilariucci, F
Frassoldati, A
Petrini, M
Silingardi, V
Citation: G. Longo et al., Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma, HAEMATOLOG, 84(5), 1999, pp. 425-430
Authors:
Stelitano, C
Morabito, F
Kropp, MG
Callea, V
Iuliano, F
Oriana, V
Levato, D
Nobile, F
Molica, S
Brugiatelli, M
Citation: C. Stelitano et al., Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases, HAEMATOLOG, 84(4), 1999, pp. 317-323
Authors:
Callea, V
Morabito, F
Oliva, BM
Stelitano, C
Levato, D
Dattilo, A
Gangemi, F
Iorfida, A
Iacopino, P
Nobile, F
Molica, S
Brugiatelli, M
Citation: V. Callea et al., Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is relatedto clinical outcome, BR J HAEM, 107(2), 1999, pp. 347-352
Authors:
Callea, V
Clo, V
Morabito, F
Baldini, L
Stelitano, C
Narni, F
Avanzini, P
Brugiatelli, M
Silingardi, V
Citation: V. Callea et al., Retrospective analysis of mantle cell lymphoma: experience of the "Gruppo Italiano per lo Studio dei Linfomi" (GISL), HAEMATOLOG, 83(11), 1998, pp. 993-997
Risultati:
1-9
|